{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:44:18Z","timestamp":1787024658211,"version":"build-2736575974"},"reference-count":81,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The main role of platelets is to contribute to hemostasis. However, under pathophysiological conditions, platelet activation may lead to thrombotic events of cardiovascular diseases. Thus, anti-thrombotic treatment is important in patients with cardiovascular disease. This review focuses on a platelet receptor, a transmembrane protein, the Multidrug Resistance Protein 4, MRP4, which contributes to platelet activation, by extruding endogenous molecules responsible for their activation and accumulation. The regulation of the intracellular concentration levels of these molecules by MRP4 turned to make the protein suspicious and at the same time an interesting regulatory factor of platelet normal function. Especially, the possible role of MRP4 in the excretion of xenobiotic and antiplatelet drugs such as aspirin is discussed, thus imparting platelet aspirin tolerance and correlating the protein with the ineffectiveness of aspirin antiplatelet therapy. Based on the above, this review finally underlines that the development of a highly selective and targeted strategy for platelet MRP4 inhibition will also lead to inhibition of platelet activation and accumulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929866528666210505120659","type":"journal-article","created":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T15:37:12Z","timestamp":1620574632000},"page":"983-995","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multidrug Resistance Protein 4 (MRP4\/ABCC4): A Suspected Efflux Transporter for Human\u2019s Platelet Activation"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7512-6818","authenticated-orcid":true,"given":"Ioannis","family":"Angelis","sequence":"first","affiliation":[{"name":"Department of Chemistry, Faculty of Organic Chemistry & Biochemistry, University of Ioannina, Ioannina,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Moussis","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Organic Chemistry & Biochemistry, University of Ioannina, Ioannina,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demokritos C.","family":"Tsoukatos","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Organic Chemistry & Biochemistry, University of Ioannina, Ioannina,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Tsikaris","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Organic Chemistry & Biochemistry, University of Ioannina, Ioannina,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0924-8579(03)00203-6","volume":"22","author":"Lage H.","year":"2003","unstructured":"Lage H.; ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int J Antimicrob Agents 2003,22(3),188-199","journal-title":"Int J Antimicrob Agents"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s00018-003-3336-9","volume":"61","author":"Jones P.M.","year":"2004","unstructured":"Jones P.M.; George A.M.; The ABC transporter structure and mechanism: perspectives on recent research. Cell Mol Life Sci 2004,61(6),682-699","journal-title":"Cell Mol Life Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1111\/j.1742-4658.2011.08235.x","volume":"278","author":"Chen Z-S.","year":"2011","unstructured":"Chen Z-S.; Tiwari A.K.; Multidrug resistance proteins (MRPs\/ABCCs) in cancer chemotherapy and genetic diseases. FEBS J 2011,278(18),3226-3245","journal-title":"FEBS J"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/bse0500179","volume":"50","author":"Slot A.J.","year":"2011","unstructured":"Slot A.J.; Molinski S.V.; Cole S.P.C.; Mammalian multidrug-resistance proteins (MRPs). Essays Biochem 2011,50(1),179-207","journal-title":"Essays Biochem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrm2646","volume":"10","author":"Rees D.C.","year":"2009","unstructured":"Rees D.C.; Johnson E.; Lewinson O.; ABC transporters: the power to change. Nat Rev Mol Cell Biol 2009,10(3),218-227","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","volume":"92","author":"Borst P.","year":"2000","unstructured":"Borst P.; Evers R.; Kool M.; Wijnholds J.; A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000,92(16),1295-1302","journal-title":"J Natl Cancer Inst"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.brainres.2009.05.095","volume":"1283","author":"Tagami M.","year":"2009","unstructured":"Tagami M.; Kusuhara S.; Honda S.; Tsukahara Y.; Negi A.; Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy. Brain Res 2009,1283,186-193","journal-title":"Brain Res"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1093\/hmg\/5.10.1649","volume":"5","author":"Allikmets R.","year":"1996","unstructured":"Allikmets R.; Gerrard B.; Hutchinson A.; Dean M.; Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. Hum Mol Genet 1996,5(10),1649-1655","journal-title":"Hum Mol Genet"},{"key":"ref=9","first-page":"3537","volume":"57","author":"Kool M.","year":"1997","unstructured":"Kool M.; de Haas M.; Scheffer G.L.; Scheper R.J.; van Eijk M.J.T.; Juijn J.A.; Baas F.; Borst P.; Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 1997,57(16),3537-3547","journal-title":"Cancer Res"},{"key":"ref=10","first-page":"2741","volume":"58","author":"Lee K.","year":"1998","unstructured":"Lee K.; Belinsky M.G.; Bell D.W.; Testa J.R.; Kruh G.D.; Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein\/canalicular multispecific organic anion transporter-related transporter. Cancer Res 1998,58(13),2741-2747","journal-title":"Cancer Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"17664","DOI":"10.1074\/jbc.M212723200","volume":"278","author":"Wielinga P.R.","year":"2003","unstructured":"Wielinga P.R.; van der Heijden I.; Reid G.; Beijnen J.H.; Wijnholds J.; Borst P.; Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 2003,278(20),17664-17671","journal-title":"J Biol Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1128\/AAC.48.5.1889-1891.2004","volume":"48","author":"Jorajuria S.","year":"2004","unstructured":"Jorajuria S.; Dereuddre-Bosquet N.; Naissant-Storck K.; Dormont D.; Clayette P.; Differential expression levels of MRP1, MRP4, and MRP5 in response to human immunodeficiency virus infection in human macrophages. Antimicrob Agents Chemother 2004,48(5),1889-1891","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.hivar.2014.03.001","volume":"13","author":"Maciejewska K.","year":"2014","unstructured":"Maciejewska K.; Parczewski M.; ABCC protein function and genetic variability in HIV infection. HIV AIDS Rev 2014,13(3),63-67","journal-title":"HIV AIDS Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"9308","DOI":"10.18632\/oncotarget.2425","volume":"5","author":"Copsel S.","year":"2014","unstructured":"Copsel S.; Bruzzone A.; May M.; Beyrath J.; Wargon V.; Cany J.; Russel F.G.M.; Shayo C.; Davio C.; Multidrug resistance protein 4\/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia. Oncotarget 2014,5(19),9308-9321","journal-title":"Oncotarget"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.2174\/092986708785132870","volume":"15","author":"Zhou S.F.","year":"2008","unstructured":"Zhou S.F.; Wang L.L.; Di Y.M.; Xue C.C.; Duan W.; Li C.G.; Li Y.; Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr Med Chem 2008,15(20),1981-2039","journal-title":"Curr Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1124\/jpet.115.225656","volume":"354","author":"Wen J.","year":"2015","unstructured":"Wen J.; Luo J.; Huang W.; Tang J.; Zhou H.; Zhang W.; The pharmacological and physiological role of multidrug-resistant protein 4. J Pharmacol Exp Ther 2015,354(3),358-375","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jacbts.2017.10.005","volume":"3","author":"Marcantoni E.","year":"2018","unstructured":"Marcantoni E.; Allen N.; Cambria M.R.; Dann R.; Cammer M.; Lhakhang T.; O\u2019Brien M.P.; Kim B.; Worgall T.; Heguy A.; Tsirigos A.; Berger J.S.; Platelet transcriptome profiling in HIV and ATP-binding cassette subfamily C member 4 (ABCC4) as a mediator of platelet activity. JACC Basic Transl Sci 2018,3(1),9-22","journal-title":"JACC Basic Transl Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1021\/ci700067f","volume":"47","author":"Pyrkov T.V.","year":"2007","unstructured":"Pyrkov T.V.; Kosinsky Y.A.; Arseniev A.S.; Priestle J.P.; Jacoby E.; Efremov R.G.; Docking of ATP to Ca-ATPase: considering protein domain motions. J Chem Inf Model 2007,47(3),1171-1181","journal-title":"J Chem Inf Model"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/sj.emboj.7600657","volume":"24","author":"Zaitseva J.","year":"2005","unstructured":"Zaitseva J.; Jenewein S.; Jumpertz T.; Holland I.B.; Schmitt L.; H662 is the linchpin of ATP hydrolysis in the nucleotide-binding domain of the ABC transporter HlyB. EMBO J 2005,24(11),1901-1910","journal-title":"EMBO J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.107.043661","volume":"74","author":"El-Sheikh A.A.K.","year":"2008","unstructured":"El-Sheikh A.A.K.; van den Heuvel J.J.M.W.; Krieger E.; Russel F.G.M.; Koenderink J.B.; Functional role of arginine 375 in transmembrane helix 6 of multidrug resistance protein 4 (MRP4\/ABCC4). Mol Pharmacol 2008,74(4),964-971","journal-title":"Mol Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bcp.2012.04.012","volume":"84","author":"Wittgen H.G.M.","year":"2012","unstructured":"Wittgen H.G.M.; van den Heuvel J.J.M.W.; Krieger E.; Schaftenaar G.; Russel F.G.M.; Koenderink J.B.; Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4\/ABCC4) plays a crucial role in substrate-specific transport activity. Biochem Pharmacol 2012,84(3),366-373","journal-title":"Biochem Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.phrs.2018.02.029","volume":"133","author":"Chantemargue B.","year":"2018","unstructured":"Chantemargue B.; Di Meo F.; Berka K.; Picard N.; Arnion H.; Essig M.; Marquet P.; Otyepka M.; Trouillas P.; Structural patterns of the human ABCC4\/MRP4 exporter in lipid bilayers rationalize clinically observed polymorphisms. Pharmacol Res 2018,133,318-327","journal-title":"Pharmacol Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"116540","DOI":"10.1016\/j.lfs.2019.06.015","volume":"231","author":"Berthier J.","year":"2019","unstructured":"Berthier J.; Arnion H.; Saint-Marcoux F.; Picard N.; Multidrug resistance-associated protein 4 in pharmacology: overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogenetics. Life Sci 2019,231(June),116540","journal-title":"Life Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"e0205175","DOI":"10.1371\/journal.pone.0205175","volume":"13","author":"Chen Y.","year":"2018","unstructured":"Chen Y.; Yuan X.; Xiao Z.; Jin H.; Zhang L.; Liu Z.; Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening. PLoS One 2018,13(10),e0205175","journal-title":"PLoS One"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1182\/blood-2003-12-4330","volume":"104","author":"Jedlitschky G.","year":"2004","unstructured":"Jedlitschky G.; Tirschmann K.; Lubenow L.E.; Nieuwenhuis H.K.; Akkerman J.W.N.; Greinacher A.; Kroemer H.K.; The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood 2004,104(12),3603-3610","journal-title":"Blood"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2353\/ajpath.2010.090425","volume":"176","author":"Jedlitschky G.","year":"2010","unstructured":"Jedlitschky G.; Cattaneo M.; Lubenow L.E.; Rosskopf D.; Lecchi A.; Artoni A.; Motta G.; Niessen J.; Kroemer H.K.; Greinacher A.; Elena R.; Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies. Am J Pathol 2010,176(3),1097-1103","journal-title":"Am J Pathol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jacc.2011.03.049","volume":"58","author":"Mattiello T.","year":"2011","unstructured":"Mattiello T.; Guerriero R.; Lotti L.; Aspirin extrusion from human platelets through multidrug resistance protein-4 \u2013 mediated transport patients after coronary artery bypass grafting. J Am Coll Cardiol 2011,58(7),752-761","journal-title":"J Am Coll Cardiol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1124\/jpet.107.131342","volume":"324","author":"Rius M.","year":"2008","unstructured":"Rius M.; Hummel-eisenbeiss J.; Keppler D.; ATP-dependent transport of leukotrienes B 4 and C 4 by the multidrug resistance protein ABCC4 (MRP4). J Pharmacol Exp Ther 2008,324(1),86-94","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2014-08-595942","volume":"126","author":"Cheepala S.B.","year":"2015","unstructured":"Cheepala S.B.; Pitre A.; Fukuda Y.; Takenaka K.; Zhang Y.; Wang Y.; Frase S.; Pestina T.; Gartner T.K.; Jackson C.; Schuetz J.D.; The ABCC4 membrane transporter modulates platelet aggregation. Blood 2015,126(20),2307-2319","journal-title":"Blood"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7555\/JBR.29.20150121","volume":"29","author":"Hou Y.","year":"2015","unstructured":"Hou Y.; Carrim N.; Wang Y.; Gallant R.C.; Marshall A.; Ni H.; Platelets in hemostasis and thrombosis: novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis. J Biomed Res 2015,29(6),437-444","journal-title":"J Biomed Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cophys.2017.11.004","volume":"1","author":"Leroy J.","year":"2018","unstructured":"Leroy J.; Vandecasteele G.; Fischmeister R.; Cyclic AMP signaling in cardiac myocytes. Curr Opin Physiol 2018,1,161-171","journal-title":"Curr Opin Physiol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.2174\/092986710792065018","volume":"17","author":"No&#xE9; L.","year":"2010","unstructured":"No&#xE9; L.; Peeters K.; Izzi B.; Van Geet C.; Freson K.; Regulators of platelet cAMP levels: clinical and therapeutic implications. Curr Med Chem 2010,17(26),2897-2905","journal-title":"Curr Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/156652411800615144","volume":"11","author":"Midgett C.","year":"2011","unstructured":"Midgett C.; Stitham J.; Martin K.; Hwa J.; Prostacyclin receptor regulation from transcription to trafficking. Curr Mol Med 2011,11(7),517-528","journal-title":"Curr Mol Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1182\/blood-2003-04-1133","volume":"103","author":"Sim D.S.","year":"2004","unstructured":"Sim D.S.; Merrill-Skoloff G.; Furie B.C.; Furie B.; Flaumenhaft R.; Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels. Blood 2004,103(6),2127-2134","journal-title":"Blood"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1182\/blood-2012-04-416594","volume":"120","author":"Burkhart J.M.","year":"2012","unstructured":"Burkhart J.M.; Vaudel M.; Gambaryan S.; Radau S.; Walter U.; Martens L.; Geiger J.; Sickmann A.; Zahedi R.P.; The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012,120(15),e73-e82","journal-title":"Blood"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"8710","DOI":"10.1021\/bi00099a032","volume":"30","author":"Dostmann W.R.G.","year":"1991","unstructured":"Dostmann W.R.G.; Taylor S.S.; Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I. Biochemistry 1991,30(35),8710-8716","journal-title":"Biochemistry"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.tips.2013.10.005","volume":"34","author":"Esseltine J.L.","year":"2013","unstructured":"Esseltine J.L.; Scott J.D.; AKAP signaling complexes: pointing towards the next generation of therapeutic targets? Trends Pharmacol Sci 2013,34(12),648-655","journal-title":"Trends Pharmacol Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/978-3-540-68964-5_23","volume":"191","author":"Walter U.","year":"2009","unstructured":"Walter U.; Gambaryan S.; cGMP and cGMP-dependent protein kinase in platelets and blood cells. Handb Exp Pharmacol 2009,191(191),533-548","journal-title":"Handb Exp Pharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1042\/bj3190067","volume":"319","author":"Dorahy D.J.","year":"1996","unstructured":"Dorahy D.J.; Lincz L.F.; Meldrum C.J.; Burns G.F.; Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36. Biochem J 1996,319(Pt 1),67-72","journal-title":"Biochem J"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1432-1033.1987.tb13357.x","volume":"167","author":"Waldmann R.","year":"1987","unstructured":"Waldmann R.; Nieberding M.; WALTER U.; Vasodilator\u2010stimulated protein phosphorylation in platelets is mediated by CAMP\u2010 and CGMP\u2010dependent protein kinases. Eur J Biochem 1987,167(3),441-448","journal-title":"Eur J Biochem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1182\/blood-2013-03-487850","volume":"122","author":"Aburima A.","year":"2013","unstructured":"Aburima A.; Wraith K.S.; Raslan Z.; Law R.; Magwenzi S.; Naseem K.M.; cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway. Blood 2013,122(20),3533-3545","journal-title":"Blood"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1161\/ATVBAHA.111.241067","volume":"32","author":"Loyau S.","year":"2012","unstructured":"Loyau S.; Dumont B.; Ollivier V.; Boulaftali Y.; Feldman L.; Ajzenberg N.; Jandrot-Perrus M.; Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity. Arterioscler Thromb Vasc Biol 2012,32(3),778-785","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"23802","DOI":"10.1016\/S0021-9258(18)54354-4","volume":"266","author":"Stroop S.D.","year":"1991","unstructured":"Stroop S.D.; Beavo J.A.; Structure and function studies of the cGMP-stimulated phosphodiesterase. J Biol Chem 1991,266(35),23802-23809","journal-title":"J Biol Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1042\/bj3290505","volume":"329","author":"Turko I.V.","year":"1998","unstructured":"Turko I.V.; Francis S.H.; Corbin J.D.; Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation. Biochem J 1998,329(Pt 3),505-510","journal-title":"Biochem J"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"9984","DOI":"10.1073\/pnas.180194597","volume":"97","author":"Yang J.","year":"2000","unstructured":"Yang J.; Wu J.; Kowalska M.A.; Dalvi A.; Prevost N.; O\u2019Brien P.J.; Manning D.; Poncz M.; Lucki I.; Blendy J.A.; Brass L.F.; Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci USA 2000,97(18),9984-9989","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1161\/ATVBAHA.115.303395","volume":"35","author":"Hechler B.","year":"2015","unstructured":"Hechler B.; Gachet C.; Purinergic receptors in thrombosis and inflammation. Arterioscler Thromb Vasc Biol 2015,35(11),2307-2315","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1039\/c1mb05145h","volume":"7","author":"Margarucci L.","year":"2011","unstructured":"Margarucci L.; Roest M.; Preisinger C.; Bleijerveld O.B.; van Holten T.C.; Heck A.J.R.; Scholten A.; Collagen stimulation of platelets induces a rapid spatial response of cAMP and cGMP signaling scaffolds. Mol Biosyst 2011,7(7),2311-2319","journal-title":"Mol Biosyst"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0005-2736(03)00022-1","volume":"1610","author":"Bodin S.","year":"2003","unstructured":"Bodin S.; Tronch&#xE8;re H.; Payrastre B.; Lipid rafts are critical membrane domains in blood platelet activation processes. Biochim Biophys Acta 2003,1610(2),247-257","journal-title":"Biochim Biophys Acta"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1538-7836.2005.01325.x","volume":"3","author":"Quinton T.M.","year":"2005","unstructured":"Quinton T.M.; Kim S.; Jin J.; Kunapuli S.P.; Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation. J Thromb Haemost 2005,3(5),1036-1041","journal-title":"J Thromb Haemost"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"7612","DOI":"10.1128\/MCB.24.17.7612-7621.2004","volume":"24","author":"Leggas M.","year":"2004","unstructured":"Leggas M.; Adachi M.; Scheffer G.L.; Sun D.; Wielinga P.; Du G.; Mercer K.E.; Zhuang Y.; Panetta J.C.; Johnston B.; Scheper R.J.; Stewart C.F.; Schuetz J.D.; Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol 2004,24(17),7612-7621","journal-title":"Mol Cell Biol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1096\/fj.11-194027","volume":"26","author":"Sassi Y.","year":"2012","unstructured":"Sassi Y.; Abi-Gerges A.; Fauconnier J.; Mougenot N.; Reiken S.; Haghighi K.; Kranias E.G.; Marks A.R.; Lacampagne A.; Engelhardt S.; Hatem S.N.; Lompre A.M.; Hulot J.S.; Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes. FASEB J 2012,26(3),1009-1017","journal-title":"FASEB J"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2015-02-631044","volume":"126","author":"Decouture B.","year":"2015","unstructured":"Decouture B.; Dreano E.; Belleville-Rolland T.; Kuci O.; Dizier B.; Bazaa A.; Coqueran B.; Lompre A.M.; Denis C.V.; Hulot J.S.; Bachelot-Loza C.; Gaussem P.; Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice. Blood 2015,126(15),1823-1830","journal-title":"Blood"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e12034","DOI":"10.14814\/phy2.12034","volume":"2","author":"Hiasa M.","year":"2014","unstructured":"Hiasa M.; Togawa N.; Miyaji T.; Omote H.; Yamamoto A.; Moriyama Y.; Essential role of vesicular nucleotide transporter in vesicular storage and release of nucleotides in platelets. Physiol Rep 2014,2(6),e12034","journal-title":"Physiol Rep"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1084\/jem.20020143","volume":"196","author":"Shrimpton C.N.","year":"2002","unstructured":"Shrimpton C.N.; Borthakur G.; Larrucea S.; Cruz M.A.; Dong J.F.; L&#xF3;pez J.A.; Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation. J Exp Med 2002,196(8),1057-1066","journal-title":"J Exp Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.phrs.2016.04.002","volume":"107","author":"Belleville-Rolland T.","year":"2016","unstructured":"Belleville-Rolland T.; Sassi Y.; Decouture B.; Dreano E.; Hulot J.S.; Gaussem P.; Bachelot-Loza C.; MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease. Pharmacol Res 2016,107,381-389","journal-title":"Pharmacol Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/09537104.2014.916792","volume":"26","author":"Raslan Z.","year":"2015","unstructured":"Raslan Z.; Naseem K.M.; Compartmentalisation of cAMP-dependent signalling in blood platelets: the role of lipid rafts and actin polymerisation. Platelets 2015,26(4),349-357","journal-title":"Platelets"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fphar.2015.00266","volume":"6","author":"Raslan Z.","year":"2015","unstructured":"Raslan Z.; Aburima A.; Naseem K.M.; The spatiotemporal regulation of cAMP Signaling in blood platelets-old friends and new players. Front Pharmacol 2015,6(Nov),266","journal-title":"Front Pharmacol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1160\/TH12-04-0232","volume":"108","author":"Borgognone A.","year":"2012","unstructured":"Borgognone A.; Pulcinelli F.M.; Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport. Thromb Haemost 2012,108(5),955-962","journal-title":"Thromb Haemost"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejphar.2014.05.001","volume":"737","author":"Lien L-M.","year":"2014","unstructured":"Lien L-M.; Chen Z-C.; Chung C-L.; Yen T-L.; Chiu H-C.; Chou D-S.; Huang S-Y.; Sheu J-R.; Lu W-J.; Lin K-H.; Multidrug resistance protein 4 (MRP4\/ABCC4) regulates thrombus formation in vitro and in vivo. Eur J Pharmacol 2014,737,159-167","journal-title":"Eur J Pharmacol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/FPC.0b013e32833997b0","volume":"20","author":"Niessen J.","year":"2010","unstructured":"Niessen J.; Jedlitschky G.; Grube M.; Kawakami H.; Kamiie J.; Ohtsuki S.; Schwertz H.; Bien S.; Starke K.; Ritter C.; Strobel U.; Greinacher A.; Terasaki T.; Kroemer H.K.; Expression of ABC-type transport proteins in human platelets. Pharmacogenet Genomics 2010,20(6),396-400","journal-title":"Pharmacogenet Genomics"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0022-2275(20)32448-2","volume":"40","author":"Sj&#xF6;linder M.","year":"1999","unstructured":"Sj&#xF6;linder M.; Tornhamre S.; Claesson H.E.; Hydman J.; Lindgren J.; Characterization of a leukotriene C4 export mechanism in human platelets: possible involvement of multidrug resistance-associated protein 1. J Lipid Res 1999,40(3),439-446","journal-title":"J Lipid Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1172\/JCI35067","volume":"118","author":"Sassi Y.","year":"2008","unstructured":"Sassi Y.; Lipskaia L.; Vandecasteele G.; Nikolaev V.O.; Hatem S.N.; Cohen Aubart F.; Russel F.G.; Mougenot N.; Vrignaud C.; Lechat P.; Lompr&#xE9; A-M.; Hulot J-S.; Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation. J Clin Invest 2008,118(8),2747-2757","journal-title":"J Clin Invest"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1160\/TH17-04-0291","volume":"118","author":"Vogt K.","year":"2018","unstructured":"Vogt K.; Mahajan-Thakur S.; Wolf R.; Br&#xF6;derdorf S.; Vogel C.; B&#xF6;hm A.; Ritter C.A.; Gr&#xE4;ler M.; Oswald S.; Greinacher A.; Kroemer H.K.; Jedlitschky G.; Rauch B.H.; Release of platelet-derived sphingosine-1-phosphate involves multidrug resistance protein 4 (MRP4\/ABCC4) and Is inhibited by statins. Thromb Haemost 2018,118(1),132-142","journal-title":"Thromb Haemost"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1055\/s-0038-1641754","volume":"118","author":"Decouture B.","year":"2018","unstructured":"Decouture B.; Becker P.H.; Therond P.; Gaussem P.; Bachelot-Loza C.; Evidence that MRP4 is only partly involved in S1P secretion during platelet activation. Thromb Haemost 2018,118(6),1116-1118","journal-title":"Thromb Haemost"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bcp.2018.03.028","volume":"152","author":"Mendes-Silverio C.B.","year":"2018","unstructured":"Mendes-Silverio C.B.; Lescano C.H.; Zaminelli T.; Sollon C.; Anh&#xEA; G.F.; Antunes E.; M&#xF3;nica F.Z.; Activation of soluble guanylyl cyclase with inhibition of multidrug resistance protein inhibitor-4 (MRP4) as a new antiplatelet therapy. Biochem Pharmacol 2018,152(January),165-173","journal-title":"Biochem Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.amjmed.2007.10.002","volume":"121","author":"Berger J.S.","year":"2008","unstructured":"Berger J.S.; Brown D.L.; Becker R.C.; Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med 2008,121(1),43-49","journal-title":"Am J Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.jacc.2007.11.080","volume":"51","author":"Gasparyan A.Y.","year":"2008","unstructured":"Gasparyan A.Y.; Watson T.; Lip G.Y.H.; The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 2008,51(19),1829-1843","journal-title":"J Am Coll Cardiol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.amjmed.2005.03.041","volume":"118","author":"Lee P.Y.","year":"2005","unstructured":"Lee P.Y.; Chen W.H.; Ng W.; Cheng X.; Kwok J.Y.Y.; Tse H.F.; Lau C.P.; Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med 2005,118(7),723-727","journal-title":"Am J Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jacc.2004.08.070","volume":"46","author":"Mason P.J.","year":"2005","unstructured":"Mason P.J.; Jacobs A.K.; Freedman J.E.; Aspirin resistance and atherothrombotic disease. J Am Coll Cardiol 2005,46(6),986-993","journal-title":"J Am Coll Cardiol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbrc.2004.03.014","volume":"317","author":"Chen C.","year":"2004","unstructured":"Chen C.; Klaassen C.D.; Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility. Biochem Biophys Res Commun 2004,317(1),46-53","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/bcp.12432","volume":"78","author":"Massimi I.","year":"2014","unstructured":"Massimi I.; Guerriero R.; Lotti L.V.; Lulli V.; Borgognone A.; Romani F.; Barill&#xE0; F.; Gaudio C.; Gabbianelli M.; Frati L.; Pulcinelli F.M.; Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets. Br J Clin Pharmacol 2014,78(6),1343-1353","journal-title":"Br J Clin Pharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"607957","DOI":"10.1155\/2015\/607957","volume":"2015","author":"Massimi I.","year":"2015","unstructured":"Massimi I.; Ciuffetta A.; Temperilli F.; Ferrandino F.; Zicari A.; Pulcinelli F.M.; Felli M.P.; Multidrug resistance protein-4 influences aspirin toxicity in human cell line. Mediators Inflamm 2015,2015(13),607957","journal-title":"Mediators Inflamm"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.vph.2015.06.016","volume":"76","author":"Temperilli F.","year":"2016","unstructured":"Temperilli F.; Di Franco M.; Massimi I.; Guarino M.L.; Guzzo M.P.; Valesini G.; Frati L.; Pulcinelli F.M.; Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and multidrug resistance protein 4 expression in human platelets. Vascul Pharmacol 2016,76,11-17","journal-title":"Vascul Pharmacol"},{"key":"ref=74","first-page":"596","volume":"2017","author":"Massimi I.","year":"2018","unstructured":"Massimi I.; Alemanno L.; Maria S.; Scd L. G.; Guerriero R.; Frati L.; Biasucci L.; Pulcinelli F. M.; MiR-21 role in aspirin- dependent PPAR&#x3B1; and multidrug resistance protein 4 upregulation. 2018,2017,596-606"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2459\/JCM.0000000000000691","volume":"19","author":"La Rosa G.","year":"2018","unstructured":"La Rosa G.; Biasucci L.M.; Mandolini C.; Massimi I.; Copponi G.; Pulcinelli F.M.; Crea F.; Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment. J Cardiovasc Med (Hagerstown) 2018,19(10),611-613","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1055\/s-0038-1629920","volume":"118","author":"Alemanno L.","year":"2018","unstructured":"Alemanno L.; Massimi I.; Klaus V.; Guarino M.L.; Maltese T.; Frati L.; Angiolillo D.J.; Pulcinelli F.M.; Impact of multidrug resistance protein-4 inhibitors on modulating platelet function and high on-aspirin treatment platelet reactivity. Thromb Haemost 2018,118(3),490-501","journal-title":"Thromb Haemost"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.3324\/haematol.2019.226266","volume":"105","author":"Giona F.","year":"2020","unstructured":"Giona F.; Massimi I.; Guarino M.L.; Santopietro M.; Laurino M.; Temperilli F.; Palumbo G.; Fo&#xE0; R.; Pulcinelli F.M.; Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia. Haematologica 2020,105(2),e65-e67","journal-title":"Haematologica"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s11239-020-02214-4","volume":"51","author":"Guarino M.L.","year":"2021","unstructured":"Guarino M.L.; Massimi I.; Alemanno L.; Conti L.; Angiolillo D.J.; Pulcinelli F.M.; MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation. J Thromb Thrombolysis 2021,51(3),625-632","journal-title":"J Thromb Thrombolysis"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bcp.2014.05.023","volume":"91","author":"Cheung L.","year":"2014","unstructured":"Cheung L.; Flemming C.L.; Watt F.; Masada N.; Yu D.M.T.; Huynh T.; Conseil G.; Tivnan A.; Polinsky A.; Gudkov A.V.; Munoz M.A.; Vishvanath A.; Cooper D.M.F.; Henderson M.J.; Cole S.P.C.; Fletcher J.I.; Haber M.; Norris M.D.; High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4). Biochem Pharmacol 2014,91(1),97-108","journal-title":"Biochem Pharmacol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/eurheartj\/ehy566.P6067","volume":"39","author":"Wolf R.","year":"2018","unstructured":"Wolf R.; Grammbauer S.; Boehm A.; Jedlitschky G.; Rauch B. H.; P6067Specific inhibition of MRP4\/ABCC4 decreases calcium influx and glycoprotein IIb\/IIIa activation in human platelets. Eur Heart J 2018,39(1),4","journal-title":"Eur Heart J"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40256-020-00460-8","volume":"21","author":"Li J.","year":"2021","unstructured":"Li J.; Chen Y.; Ou Z.; Ouyang F.; Liang J.; Jiang Z.; Chen C.; Li P.; Chen J.; Wei J.; Zeng J.; Aspirin therapy in cardiovascular disease with glucose-6-phosphate dehydrogenase deficiency, safe or not? Am J Cardiovasc Drugs 2021,21(4),377-382","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866528666210505120659","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/193183\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866528666210505120659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T09:32:34Z","timestamp":1699003954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/193183\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":81,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866528666210505120659","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}